Michael Rosenberg
5Patents
4h-index
10Co-inventors
54Inventor score
Filing activity: Jun 9, 1987 → Mar 17, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5082670A | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system | Emerging Cross-Sectional Technologies | 352 | Expired |
| US5650148A | Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system | Emerging Cross-Sectional Technologies | 49 | Expired |
| US5762926A | Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system | Emerging Cross-Sectional Technologies | 43 | Expired |
| US4948590A | Avidin or streptavidin conjugated liposomes | Emerging Cross-Sectional Technologies | 25 | Expired |
| US10900036B2 | RNA interactome of polycomb repressive complex 1 (PRC1) | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.